Funding

Harvard Ludwig Center

The Harvard Ludwig Center supports research focused on understanding the basis of intrinsic and acquired resistance to anti-cancer drugs. The Harvard Ludwig Center also provides continuing support for the development and testing of tumor atlas technologies and analytical software.

Funded By:

Ludwig Center at Harvard Medical School

Center for Cancer Systems Pharmacology

The HMS Center for Cancer Systems Pharmacology (CCSP) is an NCI Cancer Systems Biology Center of Excellence that studies responsiveness and resistance to anti-cancer drugs. The Center focuses on targeted small molecule therapies and newly emerging immune checkpoint inhibitors (ICIs), two cornerstones of precision cancer medicine.

Funded By:

NCI Cancer Systems Biology Center of Excellence grant U54-CA225088

The Bill and Melinda Gates Foundation

Funding from the Bill and Melinda Gates Foundation aims to understand and ultimately eradicate TB.

Funded By:

Bill and Melinda Gates Foundation grant INV-027106

Gray Foundation Basser Initiative

Funding from the Gray Foundation Basser Initiative is helping create a shared electronic resource for the distribution and analysis of data for the early detection, prevention and treatment of BRCA1/2-associated cancers.

Funded By:

The Gray Foundation

Human Tumor Atlas Network (HTAN)

Research on precancers and primary melanoma is supported by the the National Cancer Institute Human Tumor Atlas Network, a multi-center program within the National Cancer Institute that emerged from the Beau Biden Cancer Moonshot Initiative. HTAN aims to generate, publicly-accessible data on the spatial, genetic and epigenetic features of common human cancers and precancers.

Funded By:

NCI Human Tumor Atlas Network grant U2C-CA233262

Ludwig Cancer Research Foundation

The Ludwig Tumor Atlas is funded by a generous gift from the Ludwig Cancer Research Foundation and is coordinated by the Ludwig Tumor Branch at Princeton University.

Funded By:

Ludwig Cancer Research Foundation

The Rossy Foundation

The Rossy Foundation funds the David Liposarcoma Research Collaboration, which is led by DFCI Investigator George Demetri. This research collaboration aims to transform the treatment of this rare, underfunded, and understudied disease. As part of this effort, the LSP is collecting highly multiplexed images of liposarcomas before and after treatment.

Funded By:

David Liposarcoma Research Initiative